Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs SLJ Global Tbk. (SULI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan SLJ Global Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan SLJ Global Tbk. diperdagangkan di Rp88 (kapitalisasi pasar 568,87 M, volume 24 jam 7,01 jt). Perbedaan utamanya: SLJ Global Tbk. jauh lebih besar — sekitar 5,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SULI | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 568,87 M |
Volume | — | 7,01 jt |
Lot | — | 70,07 rb |
Perputaran | — | 617,4 jt |
Harga Rata-rata | — | 88,11 |
Nilai Transaksi | — | 617,4 jt |
Harga Ekuilibrium Indikatif | — | 88 |
Volume Ekuilibrium Indikatif | — | 163 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang SLJ Global Tbk.
PT SLJ Global (the Company) was established under the name of PT. Sumalindo Lestari Jaya in the Republic of Indonesia based on Notarial Deed No. 10 dated April 14, 1980, of Rukmasanti Hardjasatya , S.H., as amended by Deed No. 1 dated June 3, 1980, of the same notary.
Selengkapnya di halaman SULI →
